Adjuvant chemotherapy and radiation therapy (RT) versus RT alone for women with high-risk endometrial cancer: Toxicity and quality-of-life results of the randomized PORTEC-3 trial

Author(s):
Creutzberg, C.L. (0000-0002-7008-4321); Boer, S.M. de; Putter, H.; Powell, M.; Mileshkin, L.R.; Katsaros, D.; Bessette, P.; Haie-Meder, C.; Ledermann, J.A.; Ottevanger, P.B.; Khaw, P.; Colombo, A.; Fyles, A.W.; Baron, M.H.; Nijman, H.W.; Nout, R.A.; Smit, V.T.H.B.M.; Verhoeven-Adema, K.; Kruitwagen, R.F.P.M.; Kitchener, H.C.
Published
2015
Publication type
Article / Letter to editor
Date issued
2015-05-20
Language
English
Is part of
Journal of Clinical Oncology (2015), No. 15
hdl
1887/100248